Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1 1

Status

Recruiting 41Active not recruiting 21Not yet recruiting 3Completed 3Terminated 2Withdrawn 1Suspended 1Enrolling by invitation 1Available 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Breast Neoplasms 52Neoplasms 41Carcinoma, Non-Small-Cell Lung 34Prostatic Neoplasms 33Colorectal Neoplasms 32Lung Neoplasms 29Pancreatic Neoplasms 20Ovarian Neoplasms 17Multiple Myeloma 16Recurrence 15Uterine Cervical Neoplasms 13Neoplasm Metastasis 12Leukemia, Myeloid, Acute 12Carcinoma, Hepatocellular 12Melanoma 11Head and Neck Neoplasms 11Brain Neoplasms 11Endometrial Neoplasms 10Small Cell Lung Carcinoma 9Triple Negative Breast Neoplasms 8Stomach Neoplasms 8Rectal Neoplasms 8Glioblastoma 8Cholangiocarcinoma 8Carcinoma, Renal Cell 8Squamous Cell Carcinoma of Head and Neck 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Advanced Solid Tumors 7Lymphoma, Follicular 6Hematologic Neoplasms 6

Interventions

toripalimab 1pembrolizumab 1enfortumab vedotin 1disitamab vedotin 1RC48 antibody 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Urinary Bladder Neoplasms × 30 days × Clear all
NCT07643519 2026-06-11

Neoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma

University of Florida

Phase 2 Not yet recruiting
39 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT07260162 2026-06-08

PERSEVERANCE

Institut Cancerologie de l'Ouest

Phase 1 Not yet recruiting
24 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07608224 2026-05-27

HOPE-07-MIBC

West China Hospital

Phase 2/3 Not yet recruiting
240 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡